<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(18)</volume><submitter>Fan SS</submitter><pubmed_abstract>Autoimmune diseases are driven by a breach of self-tolerance, leading to chronic inflammation and organ damage. While the Th1 and Th17 paradigms have long dominated our understanding of T-cell-mediated pathology, a distinct subset of CD4&lt;sup>+&lt;/sup> T helper cells defined by the production of granulocyte-macrophage colony-stimulating factor (GM-CSF) has emerged as a central and non-redundant pathogenic driver. These GM-CSF-producing Th cells orchestrate autoimmune pathology across a spectrum of diseases, including multiple sclerosis, rheumatoid arthritis, and type 1 diabetes, among others. Mechanistically, they act as critical amplifiers of inflammation by activating and recruiting myeloid cells, which in turn mediate tissue destruction. Furthermore, they establish vicious feedback loops, </pubmed_abstract><journal>Theranostics</journal><pagination>9944-9968</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12486991</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>GM-CSF&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; Th: a central player in autoimmunity.</pubmed_title><pmcid>PMC12486991</pmcid><pubmed_authors>Fan SS</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Meng XY</pubmed_authors><pubmed_authors>Luo YB</pubmed_authors><pubmed_authors>Xu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>GM-CSF&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; Th: a central player in autoimmunity.</name><description>Autoimmune diseases are driven by a breach of self-tolerance, leading to chronic inflammation and organ damage. While the Th1 and Th17 paradigms have long dominated our understanding of T-cell-mediated pathology, a distinct subset of CD4&lt;sup>+&lt;/sup> T helper cells defined by the production of granulocyte-macrophage colony-stimulating factor (GM-CSF) has emerged as a central and non-redundant pathogenic driver. These GM-CSF-producing Th cells orchestrate autoimmune pathology across a spectrum of diseases, including multiple sclerosis, rheumatoid arthritis, and type 1 diabetes, among others. Mechanistically, they act as critical amplifiers of inflammation by activating and recruiting myeloid cells, which in turn mediate tissue destruction. Furthermore, they establish vicious feedback loops, </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-07-15T09:47:23.727Z</modification><creation>2026-07-02T03:12:37.936Z</creation></dates><accession>S-EPMC12486991</accession><cross_references><pubmed>41041077</pubmed><doi>10.7150/thno.121766</doi></cross_references></HashMap>